Research Digest: 20 Recent Studies – May 02, 2026
This research digest highlights cannabinoid-based interventions autism safety effectiveness from recent peer-reviewed studies. It covers clinical evidence on behavioral outcomes in children and adolescents with autism spectrum disorder. The curated…
What Pediatric Autism Cannabinoid Studies Actually Show
Cannabinoids for autism behavior are increasingly discussed by families seeking help for irritability, aggression, sleep, anxiety, and daily functioning. This review finds a limited but clinically relevant signal for selected outcomes, especially with…
Cannabis Medicines Show Modest Promise for Nerve Pain, But Evidence Remains Inconclusive
Cannabis medicines neuropathic pain evidence suggests potential benefits for nerve pain relief. However, study limitations like small samples and short durations hinder firm conclusions. More rigorous trials are needed to clarify efficacy and safety.
CBD and Colon Cancer: A Promising Hypothesis Built on Preclinical Ground
By influencing the serotonergic system, CBD colorectal cancer serotonergic pathway may confer both protective and potentially deleterious effects during CRC development. This 2025 review synthesizes preclinical evidence without human clinical trials. The…
Cannabis Hyperemesis Syndrome in Youth: A Narrative Review Highlights Clinical Gaps and Public Health Urgency
Cannabis hyperemesis syndrome youth review reveals clinical gaps in understanding this cyclical vomiting condition linked to chronic cannabis use. Youth are disproportionately affected by this syndrome, which remains under-recognized. This review…
CBD in Childhood Epilepsy: What the Evidence Actually Shows
Several randomized controlled trials demonstrate cannabidiol pediatric epilepsy dosing reduces seizures in syndromes like Lennox-Gastaut and Dravet. This review summarizes dosing, drug interactions, and safety monitoring for cannabidiol in pediatric…
Cannabis for Nerve Pain: Mixed Evidence From 22 Trials, No Clear Winners Yet
Neuropathic pain cannabis treatment shows promise but remains inconclusive due to study limitations. Trials reveal mixed evidence with no definitive winners yet. Careful dosing and further research are essential for clinical guidance.
What the Evidence Really Says About CBD for Children With Epilepsy
This 2025 review highlights CBD pediatric epilepsy drug interactions and their impact on seizure management in children. Pharmaceutical-grade CBD shows meaningful seizure reduction in drug-resistant epilepsy. Careful monitoring and dosing are essential…
Cannabis Hyperemesis Syndrome in Young People: What Clinicians and Parents Need to Know
Cannabis hyperemesis syndrome clinical review highlights severe vomiting and nausea linked to cannabis use in young people. This condition often leads to misdiagnosis and delayed treatment. Understanding clinical phases and symptom relief is crucial for…
Can Mouth-Dissolving Films and Gels Solve Cannabis Medicine’s Bioavailability Problem?
Oral mucosal cannabinoid bioavailability offers a promising alternative to traditional oral ingestion by bypassing first-pass metabolism. Films and gels designed for transmucosal absorption can enhance cannabinoid delivery. This review examines the…